Commissioner and Commission Staff Public Statements and Letters

Displaying 81 - 100 of 301

Statement of the Federal Trade Commission "The FTC In FY 2013: Protecting Consumers and Competition"

Before the Subcommittee On Financial Services and General Government of the Committee On Appropriations, United States House of Representatives

Jon Leibowitz, Former Chairman

Joint FDA/FTC Warning Letter Concerning Product Labeling of Human Chrorionic Gonadotropin (HCG) Drugs

LaTonya Mitchell, Director, Food and Drug Administration (FDA) Denver District Office; and Dr. Ilisa Bernstein, Acting Director, FDA Office of Compliance to Dr. Gary Arbuckle and Ms. Amy Freeze, and

Mary K. Engle, Associate Director

Mary K. Engle